Stereotactic radiotherapy plus nivolumab for NSCLC

被引:1
作者
Krug, David [1 ]
Dunst, Juergen [1 ]
机构
[1] UKSH, Klin Strahlentherapie, Radioonkol, Campus Kiel, Kiel, Germany
关键词
CELL LUNG-CANCER; THERAPY;
D O I
10.1007/s00066-023-02143-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:957 / 959
页数:3
相关论文
共 9 条
[1]   Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials [J].
Chang, Joe Y. ;
Senan, Suresh ;
Paul, Marinus A. ;
Mehran, Reza J. ;
Louie, Alexander V. ;
Balter, Peter ;
Groen, Harry J. M. ;
McRae, Stephen E. ;
Widder, Joachim ;
Feng, Lei ;
van den Borne, Ben E. E. M. ;
Munsell, Mark F. ;
Hurkmans, Coen ;
Berry, Donald A. ;
van Werkhoven, Erik ;
Kresl, John J. ;
Dingemans, Anne-Marie ;
Dawood, Omar ;
Haasbeek, Cornelis J. A. ;
Carpenter, Larry S. ;
De Jaeger, Katrien ;
Komaki, Ritsuko ;
Slotman, Ben J. ;
Smit, Egbert F. ;
Roth, Jack A. .
LANCET ONCOLOGY, 2015, 16 (06) :630-637
[2]  
Chang JY., 2023, LANCET, DOI [10.1016/S0140-6736(23)01464-2, DOI 10.1016/S0140-6736(23)01464-2]
[3]   Stereotactic Ablative Radiation Therapy Versus Surgery in Early Lung Cancer: A Meta-analysis of Propensity Score Studies [J].
Chen, Hanbo ;
Laba, Joanna M. ;
Boldt, R. Gabriel ;
Goodman, Christopher D. ;
Palma, David A. ;
Senan, Suresh ;
Louie, Alexander V. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 101 (01) :186-194
[4]   Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial [J].
Felip, Enriqueta ;
Altorki, Nasser ;
Zhou, Caicun ;
Csoszi, Tibor ;
Vynnychenko, Ihor ;
Goloborodko, Oleksandr ;
Luft, Alexander ;
Akopov, Andrey ;
Martinez-Marti, Alex ;
Kenmotsu, Hirotsugu ;
Chen, Yuh-Min ;
Chella, Antonio ;
Sugawara, Shunichi ;
Voong, David ;
Wu, Fan ;
Yi, Jing ;
Deng, Yu ;
McCleland, Mark ;
Bennett, Elizabeth ;
Gitlitz, Barbara ;
Wakelee, Heather .
LANCET, 2021, 398 (10308) :1344-1357
[5]  
leitlinienprogramm, US
[6]  
nccn, About us
[7]   Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial [J].
O'Brien, Mary ;
Paz-Ares, Luis ;
Marreaud, Sandrine ;
Dafni, Urania ;
Oselin, Kersti ;
Havel, Libor ;
Esteban, Emilio ;
Isla, Dolores ;
Martinez-Marti, Alex ;
Faehling, Martin ;
Tsuboi, Masahiro ;
Lee, Jong-Seok ;
Nakagawa, Kazuhiko ;
Yang, Jing ;
Samkari, Ayman ;
Keller, Steven M. ;
Mauer, Murielle ;
Jha, Nitish ;
Stahel, Rolf ;
Besse, Benjamin ;
Peters, Solange .
LANCET ONCOLOGY, 2022, 23 (10) :1274-1286
[8]   Stereotactic body radiotherapy versus surgery for early-stage non-small cell lung cancer: an updated meta-analysis involving 29,511 patients included in comparative studies [J].
Viani, Gustavo Arruda ;
Gouveia, Andre Guimaraes ;
Yan, Michael ;
Matsuura, Fernando Konjo ;
Moraes, Fabio Ynoe .
JORNAL BRASILEIRO DE PNEUMOLOGIA, 2022, 48 (03)
[9]   Safety and Efficacy Results From iSABR, a Phase 1 Study of Stereotactic ABlative Radiotherapy in Combination With Durvalumab for Early-Stage Medically Inoperable Non-Small Cell Lung Cancer [J].
Wu, Trudy C. ;
Stube, Annalise ;
Felix, Carol ;
Oseguera, Denise ;
Romero, Tahmineh ;
Goldman, Jonathan ;
Garon, Edward B. ;
Lee, Jay M. ;
Glaspy, John ;
Lisberg, Aaron E. ;
Rusthoven, Chad G. ;
Camidge, D. Ross ;
Siva, Shankar ;
Solomon, Benjamin ;
Lee, Alan ;
Tenn, Stephen E. ;
Shaverdian, Narek ;
Steinberg, Michael L. ;
Raldow, Ann C. ;
Lee, Percy .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (01) :118-122